Legal Representation
Attorney
Elsa D. Lemoine
USPTO Deadlines
Next Deadline
200 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
May 27, 2026
Extension Available
Until May 27, 2026
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 29, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 29, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 28, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 28, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 27, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 1, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 1, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 6, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 5, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 5, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 5, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 17, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Sep 17, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Sep 6, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 6, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 6, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 6, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 14, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 4, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of gastric and gastro-esophageal diseases, conditions or maladies
Classification
International Classes
005